Member Info for Compoundinterest

I can't see many sellers from at these levels... so looks like the direction of travel is going up. Very excited about this company and its prospects. IMO, DYOR. GLA

Agree MrShoubs, it's shocking... the market has priced the Covid/ARDS trial to pretty much fail. This will experience a significant turnaround if results to 100 patient data demonstrates strong efficacy data. Really hope so for the stake of people in India...

Does anyone have a summary of the current Warrants issued? Trying to work out if we will be significantly diluted after these are exercised?

Thanks for sharing MM. Is it common for Covid clinical trials to include Neutrophil in their exploratory objectives? I guess if not, they will have to rely on the data from SFX-01 which includes this dataset.

The SP gradually back down to 7.6p now.. the market seems to be pricing in bad news... hopefully we get a nice surprise soon! Anyone buying in at this time are quite lucky (or not).. I bought from around 10p+ averaging all the way down.

Thanks for your sharing Wyn. At 4.2-4.3p I will be a partial buyer. Happy to buy at those levels. But sentiment towards high street opening up seems to be grabbing a lot of the attention. So I am not sure how enthusiastic the market is for Eve Sleep as a online tech play. I am so far at this stage mainly attracted to this company because of the CEO's charisma and marketing ability. GLA.

wow hot off the press... thanks for timely sharing MM. Further support for NRF2 pathway benefits for Ards & Covid; hopefully that is consistent with SFX-01 clinical trials.

Welcome Geeman ! Hopefully good things will come from this. If u want decent insight and research of this company, I suggest u have a look at the MoneyMunch's previous messages. He has posts some really good detailed research.

Thanks for sharing Wyn as always. @D-Geeman- 113 or 117 a few pennies imo doesn't matter too much for Angle. Believe it could exceed a billion dollar potential in the long-term. Have you guys heard of a company called Evgen (EVG). If not, could take a look, it would be great to exchange ideas on there too. High risk, high reward... the research on sulforaphane has been pretty fascinating. Let me know if u guys get chance to review. If the tech works, then I think it's a multi-bagger like it was for Eve.

Current RSI at 40+ when price is 4.8p. Looking for re-entry at around 4.5p. IMO should be strong support at around these level before results. What do u think? With results and possible surprises around the corner? May be. fingers crossed. GLA.

Really exciting company looking to disrupt significantly the way patients are treated. Billion dollar potential. Now with US attention including IIs like Morgan Stanley, just scratching the surface. Would be great to get Soft Bank, Redmile and other biotech specialist funds on board too. Long hold. GLA.

cool Ad. City.A.M post "Profit rose 14 per cent to £14.5m" I think they got mixed up with sales since no profits yet. Hopefully we will see profitability this year.

o dear... back down to 7.5p. Does somebody know something? Strange to be selling at this point; must of lost their nerves after watching SNG.

In hindsight, what a great opportunity to load up... who knows; all happened so quickly too.

Nice one Wyn, yes I noticed that. Really good predictions and precisely timed. superb analysis

Small top-up at 101. Great opportunity. Wish had more funds to load up. Can only re-adjust portfolio. ..

Supply overhang clearing.... onwards and upwards!

Ah.. would of been good to learn how much was the milestone payments. I am guessing not that much... otherwise they would of announced it.

Think we need some institutional investor interest to get the ball moving... small buys are gradually absorbing supply overhang but not enough to move it significantly. Hoping positive data from the ARDS/Covid trial! GLA

Fascinating debates about RSI and TA. For me investing in this stock is more about it's exciting technology and it's disruptive potential!! But I do wonder how protected are there patents though, for example, how easy would it be for the likes of Thermal Fisher or Abbott or others to slightly tweak and improve their tech to make their product patent obsolete? But I guess, even if a competitor does that, they still would need a few years to register and get it to market I guess.. fingers crossed a product approval is confirmed and contracts fly in to verify the demand for this product.